Aclaris 治療公司
US ˙ NasdaqGS ˙ US00461U1051

簡介

本頁面提供了有關 Braden Michael Leonard 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Braden Michael Leonard已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:OM / Outset Medical, Inc. 10% Owner 2,519,701
US:ACRS / Aclaris Therapeutics, Inc. 10% Owner 13,950,000
US:ADVM / Adverum Biotechnologies, Inc. 10% Owner 1,958,080
US:ASTC / Astrotech Corporation 10% Owner 0
US: / AN2 THERAPEUTICS 10% Owner 3,017,432
102,076
US:TLIS / Talis Biomedical Corporation 10% Owner 248,702
33,333
US:CYT / Cyteir Therapeutics, Inc. 10% Owner 3,654,053
US:IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF 10% Owner 1,767,774
US:RVP / Retractable Technologies, Inc. 10% Owner 688,575
US:MTCR / Metacrine Inc 10% Owner 6,160,570
US:STSA / Satsuma Pharmaceuticals Inc 10% Owner 150,000
US:GMTX / Gemini Therapeutics Inc 10% Owner 247,500
US:TISUQ / ORCHIDS PAPER PRODS CO DEL 10% Owner 2,787,926
US:PRPH / ProPhase Labs, Inc. 10% Owner 627,322
US:BBW / Build-A-Bear Workshop, Inc. 1,281,000
如何解讀這些圖表

以下圖表顯示了在Braden Michael Leonard進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

ACRS / Aclaris Therapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2024-08-05 ACRS Leonard Braden Michael 206,025 1.2443 206,025 1.2443 256,357 106 4.5900 689,299 268.88
2024-08-02 ACRS Leonard Braden Michael 167,544 1.2916 167,544 1.2916 216,400
2024-07-31 ACRS Leonard Braden Michael 100,000 1.3264 100,000 1.3264 132,640
2024-07-30 ACRS Leonard Braden Michael 173,730 1.3030 173,730 1.3030 226,370
2024-07-22 ACRS Leonard Braden Michael 17,716 1.3297 17,716 1.3297 23,557
2024-07-19 ACRS Leonard Braden Michael 6,689 1.3000 6,689 1.3000 8,696
2024-07-18 ACRS Leonard Braden Michael 130,317 1.3011 130,317 1.3011 169,555
2024-07-05 ACRS Leonard Braden Michael 123,017 1.1489 123,017 1.1489 141,334
2024-07-03 ACRS Leonard Braden Michael 143,288 1.1590 143,288 1.1590 166,071
2024-07-02 ACRS Leonard Braden Michael 86,092 1.1440 86,092 1.1440 98,489
2024-07-01 ACRS Leonard Braden Michael 107,434 1.1373 107,434 1.1373 122,185
2024-06-28 ACRS Leonard Braden Michael 801,000 1.1193 801,000 1.1193 896,559
2024-06-28 ACRS Leonard Braden Michael 400,000 1.1300 400,000 1.1300 452,000
2024-06-27 ACRS Leonard Braden Michael 235,000 1.1546 235,000 1.1546 271,331
2024-06-18 ACRS Leonard Braden Michael 50,000 1.1301 50,000 1.1301 56,505
2024-06-17 ACRS Leonard Braden Michael 150,000 1.1300 150,000 1.1300 169,500
2024-06-14 ACRS Leonard Braden Michael 345,000 1.1658 345,000 1.1658 402,201
2024-06-13 ACRS Leonard Braden Michael 28,621 1.1445 28,621 1.1445 32,757
2024-06-13 ACRS Leonard Braden Michael 500,000 1.1500 500,000 1.1500 575,000
2024-06-12 ACRS Leonard Braden Michael 82,579 1.1400 82,579 1.1400 94,140
2024-06-11 ACRS Leonard Braden Michael 1,000,000 1.0800 1,000,000 1.0800 1,080,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACRS / Aclaris Therapeutics, Inc. Insider Trades
ACRS / Aclaris Therapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2026-04-23 ACRS Leonard Braden Michael 300,000 4.5300 300,000 4.5300 1,359,000 5 4.2200 -93,000 -6.84

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

ACRS / Aclaris Therapeutics, Inc. Insider Trades
BBW / Build-A-Bear Workshop, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2012-06-15 BBW Leonard Braden Michael 3,278 4.0602 3,278 4.0602 13,309 329 6.99 9,604 72.16
2012-06-14 BBW Leonard Braden Michael 21,722 4.0681 21,722 4.0681 88,367
2012-06-08 BBW Leonard Braden Michael 50,000 4.3427 50,000 4.3427 217,135
2012-06-04 BBW Leonard Braden Michael 20,000 4.4527 20,000 4.4527 89,054
2012-05-31 BBW Leonard Braden Michael 12,500 4.5074 12,500 4.5074 56,342
2012-05-25 BBW Leonard Braden Michael 5,000 4.7664 5,000 4.7664 23,832
2012-05-24 BBW Leonard Braden Michael 12,500 4.6120 12,500 4.6120 57,650
2012-05-22 BBW Leonard Braden Michael 50,000 4.6890 50,000 4.6890 234,450
2012-05-09 BBW Leonard Braden Michael 50,000 4.8605 50,000 4.8605 243,025
2012-05-08 BBW Leonard Braden Michael 100,000 4.8125 100,000 4.8125 481,250
2012-03-13 BBW Leonard Braden Michael 38,398 5.7153 38,398 5.7153 219,456
2012-03-12 BBW Leonard Braden Michael 62,002 5.3611 62,002 5.3611 332,399

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

BBW / Build-A-Bear Workshop, Inc. Insider Trades
BBW / Build-A-Bear Workshop, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2017-09-29 BBW Leonard Braden Michael 2,000 9.2000 2,000 9.2000 18,400 40 7.3500 -3,700 -20.11
2017-09-28 BBW Leonard Braden Michael 25,000 9.2056 25,000 9.2056 230,140
2017-09-26 BBW Leonard Braden Michael 7,070 9.0110 7,070 9.0110 63,708
2017-09-25 BBW Leonard Braden Michael 14,343 9.0026 14,343 9.0026 129,124
2017-09-22 BBW Leonard Braden Michael 26,206 9.0533 26,206 9.0533 237,251
2017-09-20 BBW Leonard Braden Michael 4,881 8.9657 4,881 8.9657 43,762
2017-09-19 BBW Leonard Braden Michael 17,500 9.0292 17,500 9.0292 158,011
2015-08-17 BBW Leonard Braden Michael 58,768 21.1795 58,768 21.1795 1,244,677
2015-08-14 BBW Leonard Braden Michael 4,882 21.0200 4,882 21.0200 102,620
2015-08-13 BBW Leonard Braden Michael 6,350 21.0238 6,350 21.0238 133,501
2015-03-11 BBW Leonard Braden Michael 1,034 20.1200 1,034 20.1200 20,804
2015-03-09 BBW Leonard Braden Michael 10,966 20.6700 10,966 20.6700 226,667
2014-11-18 BBW Leonard Braden Michael 19,800 18.9600 19,800 18.9600 375,408
2014-11-17 BBW Leonard Braden Michael 200 19.0000 200 19.0000 3,800
2014-11-11 BBW Leonard Braden Michael 18,418 18.4600 18,418 18.4600 339,996
2014-11-06 BBW Leonard Braden Michael 2,500 18.7000 2,500 18.7000 46,750
2014-11-05 BBW Leonard Braden Michael 29,000 18.4100 29,000 18.4100 533,890
2014-10-31 BBW Leonard Braden Michael 15,000 17.1400 15,000 17.1400 257,100
2014-10-30 BBW Leonard Braden Michael 45,000 17.0700 45,000 17.0700 768,150
2014-10-29 BBW Leonard Braden Michael 90,000 17.1100 90,000 17.1100 1,539,900
2014-10-28 BBW Leonard Braden Michael 45,000 16.9400 45,000 16.9400 762,300
2014-08-27 BBW Leonard Braden Michael 15,583 13.5000 15,583 13.5000 210,370
2014-08-26 BBW Leonard Braden Michael 60,000 13.5100 60,000 13.5100 810,600
2014-05-30 BBW Leonard Braden Michael 61,512 13.9700 61,512 13.9700 859,323
2014-05-29 BBW Leonard Braden Michael 27,120 13.9000 27,120 13.9000 376,968
2014-05-28 BBW Leonard Braden Michael 5,221 14.0200 5,221 14.0200 73,198
2014-05-27 BBW Leonard Braden Michael 31,070 14.4700 31,070 14.4700 449,583
2014-05-23 BBW Leonard Braden Michael 25,077 14.3800 25,077 14.3800 360,607
2014-05-21 BBW Leonard Braden Michael 12,841 13.5300 12,841 13.5300 173,739
2014-05-20 BBW Leonard Braden Michael 7,485 13.5400 7,485 13.5400 101,347
2014-05-19 BBW Leonard Braden Michael 24,000 13.6500 24,000 13.6500 327,600
2014-05-14 BBW Leonard Braden Michael 4,851 13.7100 4,851 13.7100 66,507
2014-05-13 BBW Leonard Braden Michael 25,823 13.8400 25,823 13.8400 357,390
2014-05-12 BBW Leonard Braden Michael 61,224 13.8200 61,224 13.8200 846,116
2014-05-09 BBW Leonard Braden Michael 13,776 13.8600 13,776 13.8600 190,935
2014-05-08 BBW Leonard Braden Michael 26,335 13.6600 26,335 13.6600 359,736
2014-05-07 BBW Leonard Braden Michael 37,014 13.6500 37,014 13.6500 505,241
2014-05-06 BBW Leonard Braden Michael 36,651 13.8700 36,651 13.8700 508,349
2013-11-15 BBW Leonard Braden Michael 4,499 10.1590 4,499 10.1590 45,705

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

BBW / Build-A-Bear Workshop, Inc. Insider Trades
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2022-06-16 IMRA Leonard Braden Michael 83,199 1.1087 20,800 4.4348 92,243 252 6.3200 39,208 42.51
2022-06-06 IMRA Leonard Braden Michael 2,630 1.1600 658 4.6400 3,051
2022-06-03 IMRA Leonard Braden Michael 30,800 1.1356 7,700 4.5424 34,976
2022-05-17 IMRA Leonard Braden Michael 26,145 1.2559 6,536 5.0236 32,836
2022-05-16 IMRA Leonard Braden Michael 15,000 1.1718 3,750 4.6872 17,577
2022-04-22 IMRA Leonard Braden Michael 8,000 1.3800 2,000 5.5200 11,040
2022-04-21 IMRA Leonard Braden Michael 552,000 1.4000 138,000 5.6000 772,800

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF Insider Trades
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2023-01-04 IMRA Leonard Braden Michael 1,250,000 4.0000 312,500 16.0000 5,000,000 16 4.0800 -3,725,000 -74.50
2023-01-03 IMRA Leonard Braden Michael 1,250,000 4.0000 312,500 16.0000 5,000,000
2022-12-30 IMRA Leonard Braden Michael 20,000 4.0400 5,000 16.1600 80,800
2022-12-23 IMRA Leonard Braden Michael 48,922 4.0600 12,230 16.2400 198,623
2022-12-22 IMRA Leonard Braden Michael 1,078 4.0600 270 16.2400 4,377

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF Insider Trades
OM / Outset Medical, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

OM / Outset Medical, Inc. Insider Trades
OM / Outset Medical, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

OM / Outset Medical, Inc. Insider Trades
PRPH / ProPhase Labs, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2014-11-07 PRPH Leonard Braden Michael 13,946 1.3800 1,395 13.8000 19,245 313 1.7100 -16,861 -87.61
2014-11-06 PRPH Leonard Braden Michael 7,500 1.3700 750 13.7000 10,275
2014-11-05 PRPH Leonard Braden Michael 43,300 1.3200 4,330 13.2000 57,156
2014-10-09 PRPH Leonard Braden Michael 169,975 1.3009 16,998 13.0090 221,120
2014-10-08 PRPH Leonard Braden Michael 114,910 1.2986 11,491 12.9860 149,222
2014-10-02 PRPH Leonard Braden Michael 16,900 1.3977 1,690 13.9770 23,621
2014-09-24 PRPH Leonard Braden Michael 4,538 1.4000 454 14.0000 6,353
2014-09-23 PRPH Leonard Braden Michael 16 1.3800 2 13.8000 22
2014-09-22 PRPH Leonard Braden Michael 44,042 1.4000 4,404 14.0000 61,659
2014-09-18 PRPH Leonard Braden Michael 2,500 1.4000 250 14.0000 3,500
2014-09-16 PRPH Leonard Braden Michael 10,000 1.4100 1,000 14.1000 14,100
2014-09-15 PRPH Leonard Braden Michael 103,918 1.4400 10,392 14.4000 149,642
2014-09-12 PRPH Leonard Braden Michael 3,409 1.5800 341 15.8000 5,386
2014-09-11 PRPH Leonard Braden Michael 14,613 1.5300 1,461 15.3000 22,358

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

PRPH / ProPhase Labs, Inc. Insider Trades
PRPH / ProPhase Labs, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2017-09-29 PRPH Leonard Braden Michael 1,695,305 2.3000 169,530 23.0000 3,899,202 5 2.0500 -3,551,664 -91.09

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

PRPH / ProPhase Labs, Inc. Insider Trades
RVP / Retractable Technologies, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
2022-05-25 RVP Leonard Braden Michael 44,877 3.9907 44,877 3.9907 179,091 57 5.0400 47,090 26.29
2022-05-23 RVP Leonard Braden Michael 18,597 3.9688 18,597 3.9688 73,808
2022-05-19 RVP Leonard Braden Michael 24,144 3.9226 24,144 3.9226 94,707
2022-05-18 RVP Leonard Braden Michael 74,928 3.7698 74,928 3.7698 282,464
2022-05-17 RVP Leonard Braden Michael 40,984 3.8475 40,984 3.8475 157,686
2022-05-16 RVP Leonard Braden Michael 97,725 3.9908 97,725 3.9908 390,001
2022-05-13 RVP Leonard Braden Michael 22,225 3.9885 22,225 3.9885 88,644
2022-05-12 RVP Leonard Braden Michael 19,931 3.7668 19,931 3.7668 75,076
2022-05-11 RVP Leonard Braden Michael 30,000 3.7985 30,000 3.7985 113,955
2022-05-10 RVP Leonard Braden Michael 20,801 3.9526 20,801 3.9526 82,218
2022-05-09 RVP Leonard Braden Michael 22,663 3.7449 22,663 3.7449 84,871
2022-05-02 RVP Leonard Braden Michael 153,428 3.8365 153,428 3.8365 588,627
2022-04-29 RVP Leonard Braden Michael 120,502 3.7816 120,502 3.7816 455,690
2022-04-28 RVP Leonard Braden Michael 156,070 3.5811 156,070 3.5811 558,902

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

RVP / Retractable Technologies, Inc. Insider Trades
RVP / Retractable Technologies, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 ACRS / Aclaris Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2022-12-29 RVP Leonard Braden Michael 3,000,000 1.6000 3,000,000 1.6000 4,800,000 319 0.9700 -1,890,000 -39.38
2022-11-29 RVP Leonard Braden Michael 250,000 2.0000 250,000 2.0000 500,000
2022-11-28 RVP Leonard Braden Michael 2,400 2.3017 2,400 2.3017 5,524

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

RVP / Retractable Technologies, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Braden Michael Leonard 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2026-05-18 2026-05-15 4 OM Outset Medical, Inc.
Common Stock 		X - Other 323,000 2,519,701 14.70 5.00 1,615,000 12,598,505
2026-05-12 2026-05-11 4 OM Outset Medical, Inc.
Common Stock 		X - Other 96,900 2,196,701 4.61 5.00 484,500 10,983,505
2026-05-12 2026-05-08 4 OM Outset Medical, Inc.
Common Stock 		X - Other 197,600 2,099,801 10.39 5.00 988,000 10,499,005
2026-04-27 2026-04-23 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		S - Sale -300,000 13,950,000 -2.11 4.53 -1,359,000 63,193,500
2026-03-04 3/A OM Outset Medical, Inc.
Common Stock 		1,902,201
2026-02-13 3 OM Outset Medical, Inc.
Common Stock 		1,902,201
2025-12-05 2025-12-04 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		S - Sale -524,560 1,958,080 -21.13 4.19 -2,200,372 8,213,558
2025-12-03 2025-12-03 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		S - Sale -222,925 2,428,640 -8.41 4.17 -929,597 10,127,429
2025-12-03 2025-12-02 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		S - Sale -51,961 2,705,565 -1.88 4.20 -218,236 11,363,373
2025-12-03 2025-12-01 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		S - Sale -300,000 2,757,526 -9.81 4.20 -1,260,000 11,581,609
2025-10-07 2025-10-03 4 ASTC ASTROTECH Corp
Common Stock 		S - Sale -9,166 0 -100.00 5.83 -53,438
2025-10-07 2025-10-03 4 ASTC ASTROTECH Corp
Common Stock 		S - Sale -220,410 0 -100.00 7.13 -1,571,634
2025-06-16 2025-05-28 4 ANTX AN2 Therapeutics, Inc.
Common Stock 		S - Sale -200,000 3,017,432 -6.22 1.09 -218,000 3,289,001
2025-05-30 2025-05-30 4 ANTX AN2 Therapeutics, Inc.
Common Stock 		S - Sale -7,000 3,217,432 -0.22 1.03 -7,227 3,321,677
2025-05-30 2025-05-30 4 ANTX AN2 Therapeutics, Inc.
Common Stock 		S - Sale -425,000 3,224,432 -11.65 1.01 -429,250 3,256,676
2025-05-30 2025-05-28 4 ANTX AN2 Therapeutics, Inc.
Common Stock 		S - Sale -100,000 3,649,432 -2.67 1.16 -116,000 4,233,341
2025-05-30 2025-05-28 4 ANTX AN2 Therapeutics, Inc.
Common Stock 		S - Sale -2,000,000 3,749,432 -34.79 1.16 -2,320,000 4,349,341
2025-04-28 2025-03-27 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 16,593 141,800 13.25 5.19 86,089 735,701
2025-04-28 2025-03-26 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 20,407 125,207 19.47 5.04 102,841 630,981
2025-04-28 2025-03-27 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 16,593 141,800 13.25 5.19 86,089 735,701
2025-04-28 2025-03-26 4/A ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 20,407 125,207 19.47 5.04 102,841 630,981
2025-04-24 2025-04-23 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 50,000 191,800 35.26 2.98 148,950 571,372
2025-04-24 2025-04-22 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 300,000 3,057,526 10.88 3.00 900,000 9,172,578
2025-04-02 2025-04-02 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 15,209 2,757,526 0.55 4.04 61,408 11,133,787
2025-04-02 2025-03-31 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 19,566 2,742,317 0.72 4.38 85,668 12,006,961
2025-03-27 2025-03-27 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase -16,593 141,800 -10.48 5.19 -86,089 735,701
2025-03-27 2025-03-26 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 20,407 125,207 19.47 5.04 102,841 630,981
2025-03-20 2025-03-20 4 ADVM Adverum Biotechnologies, Inc.
Common Stovk 		P - Purchase 30,600 2,722,761 1.14 5.61 171,767 15,283,674
2025-03-20 2025-03-19 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 25,000 2,692,161 0.94 4.94 123,390 13,287,430
2025-03-20 2025-03-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 44,341 2,667,161 1.69 4.73 209,618 12,608,737
2025-03-20 2025-03-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 18,000 2,622,820 0.69 4.60 82,800 12,064,972
2025-02-28 2025-02-28 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 85,068 2,604,820 3.38 4.60 391,015 11,973,055
2025-02-28 2025-02-27 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 86,802 2,519,752 3.57 4.46 387,094 11,236,834
2025-02-28 2025-02-26 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 164,886 2,432,950 7.27 4.01 660,979 9,752,967
2024-10-09 2024-10-07 4 OKUR OnKure Therapeutics, Inc.
Common Stock 		J - Other 102,076 102,076
2024-10-09 2024-10-07 4 OKUR OnKure Therapeutics, Inc.
Common Stock 		J - Other 345,739 345,739
2024-09-26 2024-09-25 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 68,746 3,457,395 2.03 1.50 102,872 5,173,646
2024-09-26 2024-09-24 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 29,600 3,388,649 0.88 1.41 41,866 4,792,905
2024-09-19 2024-09-18 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 806 3,359,049 0.02 1.40 1,128 4,702,669
2024-09-19 2024-09-17 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 55,300 3,358,243 1.67 1.36 75,108 4,561,166
2024-09-16 2024-09-16 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 172,747 3,302,943 5.52 1.37 236,871 4,528,995
2024-09-16 2024-09-13 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 150,000 3,130,196 5.03 1.31 196,950 4,109,947
2024-09-16 2024-09-12 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 36,176 2,980,196 1.23 1.40 50,523 4,162,142
2024-09-09 2024-09-06 4 TLIS Talis Biomedical Corp
Common Stock 		P - Purchase 25,000 248,702 11.18 1.48 37,100 369,074
2024-09-09 2024-09-05 4 TLIS Talis Biomedical Corp
Common Stock 		P - Purchase 5,100 223,702 2.33 1.40 7,140 313,183
2024-09-05 2024-09-03 4 TLIS Talis Biomedical Corp
Common Stock 		P - Purchase 500 218,602 0.23 4.00 2,000 874,408
2024-09-04 2024-08-30 4 TLIS Talis Biomedical Corp
Common Stock 		P - Purchase 151 218,602 0.07 4.25 642 929,058
2024-08-28 2024-08-28 4 TLIS Talis Biomedical Corp
Common Stock 		P - Purchase 1,215 217,951 0.56 3.96 4,815 863,674
2024-08-28 2024-08-26 4 TLIS Talis Biomedical Corp
Common Stock 		P - Purchase 13,167 216,736 6.47 3.90 51,322 844,794
2024-08-14 2024-08-14 4 ANTX AN2 Therapeutics, Inc.
Common Stock 		P - Purchase 1,500,000 5,749,432 35.30 1.04 1,560,000 5,979,409
2024-08-14 2024-08-14 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 100,487 2,944,020 3.53 1.41 142,008 4,160,489
2024-08-14 2024-08-13 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 171,339 2,843,533 6.41 1.39 238,590 3,959,620
2024-08-14 3 TLIS Talis Biomedical Corp
Common Stock 		203,569
2024-08-12 3 ANTX AN2 Therapeutics, Inc.
Common Stock 		4,249,432
2024-08-05 2024-08-05 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 206,025 14,250,000 1.47 1.24 256,357 17,731,275
2024-08-05 2024-08-02 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 167,544 14,043,975 1.21 1.29 216,400 18,139,198
2024-07-31 2024-07-31 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 100,000 13,876,421 0.73 1.33 132,640 18,405,685
2024-07-31 2024-07-30 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 173,730 13,776,421 1.28 1.30 226,370 17,950,677
2024-07-31 2024-07-30 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 85,800 2,268,064 3.93 7.15 613,470 16,216,658
2024-07-22 2024-07-22 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 17,716 13,602,691 0.13 1.33 23,557 18,087,498
2024-07-22 2024-07-19 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 6,689 13,584,975 0.05 1.30 8,696 17,660,468
2024-07-22 2024-07-18 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 130,317 13,578,286 0.97 1.30 169,555 17,666,708
2024-07-18 2024-07-18 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 80,718 2,182,264 3.84 9.11 735,736 19,891,118
2024-07-18 2024-07-17 4 ADVM Adverum Biotechnologies, Inc.
Common Stock 		P - Purchase 135,546 2,101,546 6.89 7.75 1,049,926 16,278,365
2024-07-18 3 ADVM Adverum Biotechnologies, Inc.
Common Stock 		2,103,176
2024-07-18 3 ADVM Adverum Biotechnologies, Inc.
Common Stock 		104,800
2024-07-05 2024-07-05 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 123,017 13,447,969 0.92 1.15 141,334 15,450,372
2024-07-05 2024-07-03 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 143,288 13,324,952 1.09 1.16 166,071 15,443,619
2024-07-05 2024-07-02 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 86,092 13,181,664 0.66 1.14 98,489 15,079,824
2024-07-01 2024-07-01 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 107,434 13,095,572 0.83 1.14 122,185 14,893,594
2024-07-01 2024-06-28 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 400,000 12,988,134 3.18 1.13 452,000 14,676,591
2024-07-01 2024-06-28 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 801,000 12,588,134 6.80 1.12 896,559 14,089,898
2024-07-01 2024-06-27 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 235,000 11,787,134 2.03 1.15 271,331 13,609,425
2024-06-25 2024-06-20 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		J - Other 33,333 33,333
2024-06-25 2024-06-20 4 TECX Tectonic Therapeutic, Inc.
Common Stock 		J - Other 400,355 400,355
2024-06-18 2024-06-18 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 50,000 11,552,134 0.43 1.13 56,505 13,055,067
2024-06-18 2024-06-17 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 150,000 11,502,134 1.32 1.13 169,500 12,997,411
2024-06-18 2024-06-14 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 345,000 11,352,134 3.13 1.17 402,201 13,234,318
2024-06-13 2024-06-13 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 500,000 11,007,134 4.76 1.15 575,000 12,658,204
2024-06-13 2024-06-13 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 28,621 10,507,134 0.27 1.14 32,757 12,025,415
2024-06-13 2024-06-12 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 82,579 10,478,513 0.79 1.14 94,140 11,945,505
2024-06-13 2024-06-11 4 ACRS Aclaris Therapeutics, Inc.
Common Stock 		P - Purchase 1,000,000 10,395,934 10.64 1.08 1,080,000 11,227,609
2024-05-16 3 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		2,672,194
2024-05-16 3 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		1,020,769
2024-05-16 2024-05-14 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 335,000 2,672,194 14.33 1.54 515,900 4,115,179
2024-05-16 2024-05-14 4 RPHM Reneo Pharmaceuticals, Inc.
Common Stock 		P - Purchase 79,281 2,337,194 3.51 1.56 123,678 3,646,023
2024-05-15 3 AVRO AVROBIO, Inc.
Common Stock 		4,471,380
2024-05-15 3/A AVRO AVROBIO, Inc.
Common Stock 		4,471,380
2024-05-15 3/A AVRO AVROBIO, Inc.
Common Stock 		400,000
2024-05-15 2024-05-14 4 AVRO AVROBIO, Inc.
Common Stock 		P - Purchase 296,882 4,768,262 6.64 1.30 385,947 6,198,741
2024-05-15 2024-05-13 4 AVRO AVROBIO, Inc.
Common Stock 		P - Purchase 216,053 4,471,380 5.08 1.26 272,227 5,633,939
2024-05-15 2024-05-13 4 AVRO AVROBIO, Inc.
Common Stock 		P - Purchase 253,700 4,255,327 6.34 1.24 313,320 5,255,329
2024-03-25 2024-03-20 4 CYT Cyteir Therapeutics, Inc.
Common Stock, par value $0.001 per share 		P - Purchase 170,589 3,654,053 4.90 2.95 503,238 10,779,456
2024-03-19 3 CYT Cyteir Therapeutics, Inc.
Common Stock, par value $0.001 per share 		3,369,687
2024-03-19 3 CYT Cyteir Therapeutics, Inc.
Common Stock, par value $0.001 per share 		335,000
2024-03-19 2024-03-18 4 CYT Cyteir Therapeutics, Inc.
Common Stock, par value $0.001 per share 		P - Purchase 113,777 3,483,464 3.38 3.01 342,469 10,485,227
2024-02-08 3 ACRS Aclaris Therapeutics, Inc.
Common Stock 		9,395,934
2023-01-05 2023-01-03 4/A IMRA IMARA Inc.
Common Stock 		S - Sale -1,250,000 1,767,774 -41.42 4.00 -5,000,000 7,071,096
2023-01-04 2023-01-04 4 IMRA IMARA Inc.
Common Stock 		S - Sale -1,250,000 1,767,774 -41.42 4.00 -5,000,000 7,071,096
2022-12-30 2022-12-30 4 IMRA IMARA Inc.
Common Stock 		S - Sale -20,000 230,000 -8.00 4.04 -80,800 929,200
2022-12-29 2022-12-29 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		S - Sale -3,000,000 688,575 -81.33 1.60 -4,800,000 1,101,720
2022-12-29 2022-12-29 4 IMRA IMARA Inc.
Common Stock 		S - Sale -19,843 250,000 -7.35 4.04 -80,166 1,010,000
2022-12-29 2022-12-28 4 IMRA IMARA Inc.
Common Stock 		S - Sale -157 269,843 -0.06 4.04 -634 1,090,166
2022-12-27 2022-12-23 4 IMRA IMARA Inc.
Common Stock 		S - Sale -48,922 270,000 -15.34 4.06 -198,623 1,096,200
2022-12-27 2022-12-22 4 IMRA IMARA Inc.
Common Stock 		S - Sale -1,078 318,922 -0.34 4.06 -4,377 1,294,823
2022-12-21 2022-12-21 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 120,099 6,160,570 1.99 0.40 48,040 2,464,228
2022-12-21 2022-12-20 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 50,122 6,040,471 0.84 0.38 19,001 2,289,943
2022-12-21 2022-12-19 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 101,384 5,990,349 1.72 0.40 40,554 2,396,140
2022-12-02 2022-12-02 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 190,971 6,612,311 2.97 0.34 65,599 2,271,329
2022-11-30 2022-11-29 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		S - Sale -250,000 3,688,575 -6.35 2.00 -500,000 7,377,150
2022-11-30 2022-11-28 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		S - Sale -2,400 3,918,575 -0.06 2.30 -5,524 9,019,384
2022-11-25 2022-11-23 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 75,000 6,421,340 1.18 0.33 24,652 2,110,694
2022-11-23 2022-11-21 4 STSA Satsuma Pharmaceuticals, Inc.
Common Stock 		P - Purchase 150,000 150,000 0.71 106,740 106,740
2022-11-18 2022-11-18 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 133,688 6,346,340 2.15 0.39 51,751 2,456,668
2022-11-18 2022-11-17 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 93,879 6,212,652 1.53 0.36 33,900 2,243,389
2022-11-18 2022-11-16 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 162,928 6,118,733 2.74 0.36 59,289 2,226,607
2022-11-16 3 STSA Satsuma Pharmaceuticals, Inc.
Common Stock 		5,608,306
2022-11-16 2022-11-15 4 STSA Satsuma Pharmaceuticals, Inc.
Common Stock 		P - Purchase 300,694 6,440,000 4.90 0.63 188,956 4,046,896
2022-11-16 2022-11-15 4 STSA Satsuma Pharmaceuticals, Inc.
Common Stock 		P - Purchase 531,000 6,139,306 9.47 0.63 336,707 3,892,934
2022-11-16 2022-11-14 4 STSA Satsuma Pharmaceuticals, Inc.
Common Stock 		P - Purchase 5,608,306 5,608,306 0.69 3,868,609 3,868,609
2022-11-09 2022-11-09 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 39,816 5,888,965 0.68 0.39 15,528 2,296,696
2022-11-09 2022-11-08 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 500 5,849,149 0.01 0.40 200 2,339,660
2022-11-09 2022-11-07 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 123,954 5,848,649 2.17 0.42 52,346 2,469,884
2022-10-31 2022-10-28 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 45,022 5,724,695 0.79 0.40 18,000 2,288,733
2022-10-31 2022-10-27 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 767,507 5,679,673 15.62 0.39 299,328 2,215,072
2022-10-27 2022-10-26 4 GMTX Gemini Therapeutics, Inc. /DE
Common Stock 		S - Sale -22,500 247,500 -8.33 2.09 -47,025 517,275
2022-10-26 3 MTCR Metacrine, Inc.
Common Stock 		3,824,354
2022-10-26 3 MTCR Metacrine, Inc.
Common Stock 		600,000
2022-10-26 2022-10-26 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 588,533 4,912,166 13.61 0.35 208,223 1,737,924
2022-10-26 2022-10-25 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 499,279 4,323,633 13.06 0.35 175,596 1,520,622
2022-10-26 2022-10-24 4 MTCR Metacrine, Inc.
Common Stock 		P - Purchase 174,354 3,824,354 4.78 0.34 59,280 1,300,280
2022-10-18 2022-10-18 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 50,000 5,955,845 0.85 0.39 19,375 2,307,890
2022-10-18 2022-10-14 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 166,434 5,905,845 2.90 0.38 62,463 2,216,464
2022-09-27 2022-09-27 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 157,929 5,739,311 2.83 0.44 69,868 2,539,071
2022-09-27 2022-09-26 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 100,000 5,581,382 1.82 0.44 44,050 2,458,599
2022-09-27 2022-09-23 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 100,000 5,481,382 1.86 0.43 42,690 2,340,002
2022-09-07 2022-09-02 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 129,990 5,381,382 2.48 0.47 61,017 2,526,021
2022-09-07 2022-09-01 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 122,070 5,251,392 2.38 0.46 56,286 2,421,417
2022-08-25 3 ASTC ASTROTECH Corp
Common Stock 		5,129,322
2022-08-25 3 ASTC ASTROTECH Corp
Common Stock 		350,000
2022-08-25 2022-08-24 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 167,589 5,139,322 3.37 0.47 79,554 2,439,636
2022-08-25 2022-08-23 4 ASTC ASTROTECH Corp
Common Stock 		P - Purchase 311,733 4,961,733 6.70 0.45 139,345 2,217,895
2022-06-21 2022-06-16 4 IMRA IMARA Inc.
Common Stock 		P - Purchase 83,199 3,017,774 2.84 1.11 92,243 3,345,806
2022-06-07 2022-06-06 4 IMRA IMARA Inc.
Common Stock 		P - Purchase 2,630 2,934,575 0.09 1.16 3,051 3,404,107
2022-06-07 2022-06-03 4 IMRA IMARA Inc.
Common Stock 		P - Purchase 30,800 2,931,945 1.06 1.14 34,976 3,329,517
2022-05-25 2022-05-25 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 44,877 3,766,875 1.21 3.99 179,091 15,032,468
2022-05-25 2022-05-23 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 18,597 3,721,998 0.50 3.97 73,808 14,771,866
2022-05-19 2022-05-19 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 24,144 3,703,401 0.66 3.92 94,707 14,526,961
2022-05-19 2022-05-18 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 74,928 3,679,257 2.08 3.77 282,464 13,870,063
2022-05-19 2022-05-17 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 40,984 3,604,329 1.15 3.85 157,686 13,867,656
2022-05-18 2022-05-17 4 IMRA IMARA Inc.
Common Stock 		P - Purchase 26,145 2,901,145 0.91 1.26 32,836 3,643,548
2022-05-18 2022-05-16 4 IMRA IMARA Inc.
Common Stock 		P - Purchase 15,000 2,875,000 0.52 1.17 17,577 3,368,925
2022-05-16 2022-05-16 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 97,725 3,563,345 2.82 3.99 390,001 14,220,597
2022-05-16 2022-05-13 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 22,225 3,465,620 0.65 3.99 88,644 13,822,625
2022-05-16 2022-05-12 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 19,931 3,443,395 0.58 3.77 75,076 12,970,580
2022-05-11 2022-05-11 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 30,000 3,423,464 0.88 3.80 113,955 13,004,028
2022-05-11 2022-05-10 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 20,801 3,393,464 0.62 3.95 82,218 13,413,006
2022-05-11 2022-05-09 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 22,663 3,372,663 0.68 3.74 84,871 12,630,286
2022-05-02 3 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		3,350,000
2022-05-02 3 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		387,500
2022-05-02 2022-05-02 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 153,428 3,350,000 4.80 3.84 588,627 12,852,275
2022-05-02 2022-04-29 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 120,502 3,196,572 3.92 3.78 455,690 12,088,157
2022-05-02 2022-04-28 4 RVP RETRACTABLE TECHNOLOGIES INC
Common Stock 		P - Purchase 156,070 3,076,070 5.34 3.58 558,902 11,015,714
2022-04-25 3 IMRA IMARA Inc.
Common Stock 		2,860,000
2022-04-25 3 IMRA IMARA Inc.
Common Stock 		320,000
2022-04-25 2022-04-22 4 IMRA IMARA Inc.
Common Stock 		P - Purchase 8,000 2,860,000 0.28 1.38 11,040 3,946,800
2022-04-25 2022-04-21 4 IMRA IMARA Inc.
Common Stock 		P - Purchase 552,000 2,852,000 24.00 1.40 772,800 3,992,800
2022-04-13 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock 		5,000,000
2022-04-13 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock 		270,000
2022-04-13 2022-04-13 4 GMTX Gemini Therapeutics, Inc. /DE
Common Stock 		P - Purchase 191,769 5,000,000 3.99 1.52 291,604 7,603,000
2022-04-13 2022-04-12 4 GMTX Gemini Therapeutics, Inc. /DE
Common Stock 		P - Purchase 203,744 4,808,231 4.42 1.42 290,193 6,848,363
2022-04-13 2022-04-12 4 GMTX Gemini Therapeutics, Inc. /DE
Common Stock 		P - Purchase 55,000 270,000 25.58 1.36 75,075 368,550
2022-04-13 2022-04-11 4 GMTX Gemini Therapeutics, Inc. /DE
Common Stock 		P - Purchase 504,487 4,604,487 12.30 1.35 681,057 6,216,057
2019-04-10 3 TISUQ Orchids Paper Products CO /DE
Common Stock 		2,787,926
2019-04-10 3 TISUQ Orchids Paper Products CO /DE
Common Stock 		1,585,963
2019-04-10 3 TISUQ Orchids Paper Products CO /DE
Common Stock 		2,787,926
2019-04-10 3 TISUQ Orchids Paper Products CO /DE
Common Stock 		1,585,963
2019-04-10 3 TISUQ Orchids Paper Products CO /DE
Common Stock 		2,787,926
2019-04-10 3 TISUQ Orchids Paper Products CO /DE
Common Stock 		1,585,963
2017-10-02 2017-09-29 4 PRPH ProPhase Labs, Inc.
Common Stock 		S - Sale -1,695,305 627,322 -72.99 2.30 -3,899,202 1,442,841
2017-10-02 2017-09-29 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -2,000 1,281,000 -0.16 9.20 -18,400 11,785,200
2017-10-02 2017-09-28 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -25,000 1,283,000 -1.91 9.21 -230,140 11,810,785
2017-09-26 2017-09-26 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -7,070 1,308,000 -0.54 9.01 -63,708 11,786,388
2017-09-26 2017-09-25 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -14,343 1,315,070 -1.08 9.00 -129,124 11,839,049
2017-09-26 2017-09-22 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -26,206 1,329,413 -1.93 9.05 -237,251 12,035,575
2017-09-21 2017-09-20 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -4,881 1,355,619 -0.36 8.97 -43,762 12,154,073
2017-09-21 2017-09-19 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -17,500 1,360,500 -1.27 9.03 -158,011 12,284,227
2017-09-21 2017-09-20 4/A BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -4,881 1,355,619 -0.36 8.97 -43,762 12,154,073
2017-09-21 2017-09-19 4/A BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -17,500 1,360,500 -1.27 9.03 -158,011 12,284,227
2017-09-18 2017-09-18 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -34,154 1,378,000 -2.42 9.01 -307,779 12,417,847
2017-09-18 2017-09-15 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -5,846 1,412,154 -0.41 9.00 -52,614 12,709,386
2017-09-18 2017-09-14 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -40,000 1,418,000 -2.74 8.98 -359,132 12,731,229
2017-05-15 2017-05-11 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		A - Award 7,747 149,520 5.46
2016-05-16 2016-05-12 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		A - Award 5,874 142,043 4.31
2015-08-17 2015-08-17 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -58,768 1,458,000 -3.87 21.18 -1,244,677 30,879,711
2015-08-17 2015-08-14 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -4,882 1,516,768 -0.32 21.02 -102,620 31,882,463
2015-08-17 2015-08-13 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -6,350 1,521,650 -0.42 21.02 -133,501 31,990,865
2015-06-04 2015-05-14 4/A BBW BUILD A BEAR WORKSHOP INC
Common Stock 		A - Award 4,378 136,169 3.32
2015-05-19 2015-05-14 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		A - Award 5 136,753 0.00
2015-03-11 2015-03-11 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -1,034 1,528,000 -0.07 20.12 -20,804 30,743,360
2015-03-11 2015-03-09 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -10,966 1,529,034 -0.71 20.67 -226,667 31,605,133
2015-01-14 2015-01-12 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale X -120,000 1,540,000 -7.23 20.23 -2,427,240 31,149,580
2015-01-09 2015-01-09 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale X -1,171 1,660,000 -0.07 19.54 -22,881 32,436,400
2015-01-09 2015-01-08 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale X -58,829 1,661,171 -3.42 19.54 -1,149,636 32,462,604
2015-01-09 2015-01-07 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale X -48,200 1,720,000 -2.73 19.25 -927,754 33,106,560
2015-01-06 2014-01-02 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale X -11,800 1,768,200 -0.66 19.76 -233,168 34,939,632
2014-11-18 2014-11-18 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -19,800 1,780,000 -1.10 18.96 -375,408 33,748,800
2014-11-18 2014-11-17 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -200 1,799,800 -0.01 19.00 -3,800 34,196,200
2014-11-13 2014-11-11 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -18,418 1,800,000 -1.01 18.46 -339,996 33,228,000
2014-11-07 2014-11-07 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 13,946 2,322,627 0.60 1.38 19,245 3,205,225
2014-11-07 2014-11-06 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 7,500 2,308,681 0.33 1.37 10,275 3,162,893
2014-11-07 2014-11-05 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 43,300 2,301,181 1.92 1.32 57,156 3,037,559
2014-11-07 2014-11-06 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -2,500 1,818,418 -0.14 18.70 -46,750 34,004,417
2014-11-07 2014-11-05 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -29,000 1,820,918 -1.57 18.41 -533,890 33,523,100
2014-11-03 2014-10-31 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -15,000 1,849,918 -0.80 17.14 -257,100 31,707,595
2014-10-30 2014-10-30 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -45,000 1,864,918 -2.36 17.07 -768,150 31,834,150
2014-10-30 2014-10-29 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -90,000 1,909,918 -4.50 17.11 -1,539,900 32,678,697
2014-10-30 2014-10-28 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -45,000 1,999,918 -2.20 16.94 -762,300 33,878,611
2014-10-10 2014-10-09 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 169,975 2,257,881 8.14 1.30 221,120 2,937,277
2014-10-10 2014-10-08 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 114,910 2,087,906 5.82 1.30 149,222 2,711,355
2014-10-06 2014-10-02 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 16,900 1,972,996 0.86 1.40 23,621 2,757,657
2014-09-24 2014-09-24 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 4,538 1,956,096 0.23 1.40 6,353 2,738,534
2014-09-24 2014-09-23 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 16 1,951,558 0.00 1.38 22 2,693,150
2014-09-24 2014-09-22 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 44,042 1,951,542 2.31 1.40 61,659 2,732,159
2014-09-18 2014-09-18 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 2,500 1,907,500 0.13 1.40 3,500 2,670,500
2014-09-18 2014-09-16 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 10,000 1,905,000 0.53 1.41 14,100 2,686,050
2014-09-15 2014-09-15 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 103,918 1,895,000 5.80 1.44 149,642 2,728,800
2014-09-15 2014-09-12 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 3,409 1,791,082 0.19 1.58 5,386 2,829,910
2014-09-15 2014-09-11 4 PRPH ProPhase Labs, Inc.
Common Stock 		P - Purchase 14,613 1,787,673 0.82 1.53 22,358 2,735,140
2014-09-11 3 PRPH ProPhase Labs, Inc.
Common Stock 		3,546,120
2014-09-11 3 PRPH ProPhase Labs, Inc.
Common Stock 		3,546,120
2014-08-28 2014-08-27 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -15,583 2,044,918 -0.76 13.50 -210,370 27,606,393
2014-08-28 2014-08-26 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -60,000 2,060,501 -2.83 13.51 -810,600 27,837,369
2014-06-02 2014-05-30 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -61,512 2,120,501 -2.82 13.97 -859,323 29,623,399
2014-06-02 2014-05-29 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -27,120 2,182,013 -1.23 13.90 -376,968 30,329,981
2014-05-28 2014-05-28 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -5,221 2,209,133 -0.24 14.02 -73,198 30,972,045
2014-05-28 2014-05-27 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -31,070 2,214,354 -1.38 14.47 -449,583 32,041,702
2014-05-28 2014-05-23 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -25,077 2,245,424 -1.10 14.38 -360,607 32,289,197
2014-05-21 2014-05-21 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -12,841 2,270,501 -0.56 13.53 -173,739 30,719,879
2014-05-21 2014-05-20 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -7,485 2,283,342 -0.33 13.54 -101,347 30,916,451
2014-05-21 2014-05-19 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -24,000 2,290,827 -1.04 13.65 -327,600 31,269,789
2014-05-15 2014-05-14 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -4,851 2,314,827 -0.21 13.71 -66,507 31,736,278
2014-05-15 2014-05-13 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -25,823 2,319,678 -1.10 13.84 -357,390 32,104,344
2014-05-12 2014-05-12 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -61,224 2,345,501 -2.54 13.82 -846,116 32,414,824
2014-05-12 2014-05-09 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -13,776 2,406,725 -0.57 13.86 -190,935 33,357,208
2014-05-12 2014-05-08 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		A - Award 5,495 131,791 4.35
2014-05-08 2014-05-08 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -26,335 2,420,501 -1.08 13.66 -359,736 33,064,044
2014-05-08 2014-05-07 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -37,014 2,446,836 -1.49 13.65 -505,241 33,399,311
2014-05-08 2014-05-06 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -36,651 2,483,850 -1.45 13.87 -508,349 34,451,000
2013-11-18 2013-11-15 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		S - Sale -4,499 2,520,501 -0.18 10.16 -45,705 25,605,770
2012-11-15 2012-11-14 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		A - Award 10,492 126,296 9.06
2012-06-15 2012-06-15 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 3,278 2,525,000 0.13 4.06 13,309 10,252,005
2012-06-15 2012-06-14 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 21,722 2,521,722 0.87 4.07 88,367 10,258,617
2012-06-11 2012-06-08 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 50,000 2,500,000 2.04 4.34 217,135 10,856,750
2012-06-04 2012-06-04 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 20,000 2,450,000 0.82 4.45 89,054 10,909,115
2012-06-04 2012-05-31 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 12,500 2,430,000 0.52 4.51 56,342 10,952,982
2012-05-29 2012-05-25 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 5,000 2,417,500 0.21 4.77 23,832 11,522,772
2012-05-29 2012-05-24 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 12,500 2,412,500 0.52 4.61 57,650 11,126,450
2012-05-23 2012-05-22 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 50,000 2,400,000 2.13 4.69 234,450 11,253,600
2012-05-10 2012-05-09 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 50,000 2,350,000 2.17 4.86 243,025 11,422,175
2012-05-10 2012-05-08 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 100,000 2,300,000 4.55 4.81 481,250 11,068,750
2012-03-14 2012-03-13 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 38,398 2,200,000 1.78 5.72 219,456 12,573,660
2012-03-14 2012-03-12 4 BBW BUILD A BEAR WORKSHOP INC
Common Stock 		P - Purchase 62,002 2,161,602 2.95 5.36 332,399 11,588,564
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）